Frank Aquila Quotations

At the end of the day when they step back and look at it, fundamentally their view can't be changed by this.

When all is said and done, what you'll probably see is some sort of negotiated settlement here, whether it's a breakup fee, or lower purchase price. Neither company has a strong interest in seeing this resolved in the court.

I think we're going to see the most direct impact in 2006 and 2007, and maybe some further impact in 2008.

There is really a trend of consolidation across many, many industries and geographies. The pipeline is full, and I think we'll see a lot of transactions in the next few months.

Neither company has a strong interest in seeing this resolved in the court.

China and India have rapidly growing economies and a great challenge for them going forward will be finding energy assets to keep their economies growing.

My gut tells me that these guys will renegotiate the price and there will be a significant haircut. Assuming they're reasonable and want to get the deal done, there's got to be some middle ground they can find.

When we look back in three years, there's going to be a higher likelihood that those companies that repatriated substantial non-U.S. profits have done major transactions compared with companies that have not repatriated assets.

It's very clear Boston Scientific is not making this acquisition for what this company can do in 2006, 2007. This is a long-term strategic acquisition for them.

Essentially, they (Guidant) are going to say ... yes there have been issues at Guidant, but do those issues give rise to a right on the part of Johnson & Johnson to walk away from the transaction?